Ezaki Glico Co. is a food company headquartered in Osaka, Japan. It has 11 business locations and 23 group companies in Japan, and 12 subsidiaries in nine countries. Ezaki Glico operates a total of 19 plants and has 5,210 employees all over the world. Since the launch in 1922 of the nutritious and fortified Glico caramel in its distinctive red box, the business activities of Ezaki Glico have adhered to the corporate philosophy of "Enhancing Public Health Through Food." Upon the 70th anniversary of Ezaki Glico in 1992, this same spirit and dedication have been incorporated into the revised corporate philosophy of "A Wholesome Life in the Best of Taste." Glico caramel – the company's first product – incorporates the innovative creativeness of Mr. Riichi Ezaki, the company's founder. From the beginning, all personnel working for the company have been dedicated to further enhancing people's health and quality of life. This has led to the expansion of business lines beyond confectionery to include ice cream products, processed foods, desserts, milk products, baby formula, food ingredients, and ingredients for cosmetic and health products.

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

Corixa is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune diseases, cancer and infectious diseases by understanding and directing the immune system. Having founded in 1994, the company conducted various preclinical development programs, including the BEXXAR® therapy and the MELACINE® vaccine. Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. The company partners with numerous developers and marketers of pharmaceuticals, targeting products that are powered by Corixa™ technology with the goal of making its potential products available to patients around the world. Corixa was acquired by GlaxoSmithKline on 12 July 2005, and GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines. The company ceased operations in March 2006.

Anhui Yinchuang Biotechnology Co., Ltd., established on 2017-06-05, Business scope includes general items:Engineering and Technology Research and Experimental Development;Fermentation process optimization technology research and development;R&D of industrial enzyme preparations;Biochemical product technology research and development;Biomass liquid fuel production process research and development;Research and development of biopesticide technology;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Feed Raw Material Sales;Feed Additive Sales;Food Additive Sales;Healthy food(prepackaged)Sales(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)licensed items:feed production;Feed additive production;Food additive production;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhucheng Dongxiao Biotechnology Co. Ltd. is a Chinese private company that manufactures and exports dextrose monohydrate syrups and sugar products.

Shandong Runde Biotechnology Co., Ltd., established on 2014-10-17, Business scope includes glucosamine hydrochloride,Glucosamine Sulfate,D-ribose,N-Acetyl Glucosamine and Derivatives,Research and development of glucosamine salts and derivatives,Production,Sales;food additives,Development of Feed Additives,Production,Sales;Import and export;Technology development in the field of biotechnology,technical consulting,technology transfer,Technical Services;electricity supply.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Nature Biological Group Co., Ltd., established on 2006-06-09, Business scope includes general items:Food Additive Sales;Feed Raw Material Sales;Machinery sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:food production;food business;Food additive production;Health food production;Health food sales;feed production;Sewage Treatment and Its Reuse;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Serum Institute of India Pvt. Ltd. is the vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 140 countries across the globe in their national immunization programs, saving millions of lives throughout the world.

Wuhan Zhongke Optics Valley Green Biotechnology offers customers services including new product research and development, technical engineering, technology validation, and promotion. They provide service to customers and promote the development of the bioindustry based on the principles of being customer-centered, market-oriented, technology-supported, talent-based, and rule-protected.

Jiangsu Haifei Biotechnology Co., Ltd., established on 2018-11-08, Business scope includes hyaluronic acid,Glucosamine,Pullulan,Lycopene,Production and sales of astaxanthin;Biological fermentation products,biomedicine,food additives,Health products,Cosmetic Raw Materials,feed,biological fertilizer,Technology development of biological products in environmental protection and other fields,technical consulting,Technology Transfer and Sales;Chemical raw materials and products,daily necessities,sales of cosmetics;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)